drugset
drugset / Trial / NCT04678388

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

NCT04678388 ↗

Phase 1 Unknown 24 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers under Fasting Conditions

Timeline

Start
2020-10-29
Primary completion
2020-12-12
Completion
2020-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-385 Unknown 64 mg Oral
Subject D744 Unknown — Oral

Indications

cardiovascular disorder